Regulation of exogenous gene expression by superoxide

Pharmaceutical Research

Volumn 23, Issue 11, 2006, Pages 2536-2541

  Kinoshita, Atsushi ^a,b   Kobayashi, Daisuke ^a   Saitoh, Yukiya ^a   Tanabe, Naoto ^a   Uchino, Katsuyoshi ^b   Nishiguchi, Kohshi ^c   Okumura, Katsuhiko ^c   Komada, Fusao ^a,d  

^a JOSAI UNIVERSITY   (Japan)

^b TOKYO TEISHIN HOSPITAL   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d HIMEJI DOKKYO UNIVERSITY   (Japan)

Author keywords

AP 1; Cytomegalovirus; Gene regulation; Long terminal repeat; Superoxide

Indexed keywords

COMPLEMENTARY DNA; COPPER ZINC SUPEROXIDE DISMUTASE; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; OXYGEN RADICAL; PROTEIN C FOS; PROTEIN C JUN; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR AP 1; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL BASED GENE THERAPY; CHEMICAL COMPOSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; ENZYME ACTIVITY; FLUOROMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; LONG TERMINAL REPEAT; NONHUMAN; OXIDATIVE STRESS; PLASMID VECTOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; VIRAL GENE THERAPY;

ANIMALS; CELL LINE; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; GENE THERAPY; GENES, FOS; GENES, JUN; PARAQUAT; RATS; RNA, MESSENGER; SUPEROXIDE DISMUTASE; SUPEROXIDES; TERMINAL REPEAT SEQUENCES;

EID: 33750634287     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9076-4     Document Type: Article

References (38)

1. D. Dreher and A. F. Junod. Role of oxygen free radicals in cancer development. Eur. J. Cancer 32A:30-38 (1996).
2. M. D. Evans, M. Dizdaroglu, and M. S. Cooke. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 567:1-61 (2004).
3. D. Bandyopadhyay, A. Chattopadhyay, G. Ghosh, and A. G. Datta. Oxidative stress-induced ischemic heart disease: protection by antioxidants. Curr. Med. Chem. 11:369-387 (2004).
4. F. M. Veronese, P. Caliceti, O. Schiavon, and M. Sergi. Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv. Drug Deliv. Rev. 54:587-606 (2002).
5. B. Young, J. W. Runge, K. S. Waxman, T. Harrington, J. Wilberger, J. P. Muizelaar, A. Boddy, and J. W. Kupiec. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA 276:538-543 (1996).
6. F. Komada, K. Nishiguchi, Y. Tanigawara, S. Iwakawa, and K. Okumura. Effects of secretable SOD delivered by genetically modified cells on xanthine/xanthine oxidase and paraquat-induced cytotoxicity in vitro. Biol. Pharm. Bull. 22:846-853 (1999).
7. K. Okumura, K. Nishiguchi, Y. Tanigawara, S. Mori, S. Iwakawa, and F. Komada. Enhanced anti-inflammatory effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblast in vitro and in vivo. Pharm. Res. 14:1223-1227 (1997).
8. K. Nishiguchi, F. Komada, Y. Tanigawara, Y. Sakai, S. Iwakawa, and K. Okumura. Effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts on cold-induced skin edema in rats. Biol. Pharm. Bull. 12:1379-1381 (1998).
9. C. A. Mullen, K. Snitzer, K. W. Culver, R. A. Morgan, W. F. Anderson, and R. M. Blaese. Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector. Hum. Gene Ther. 7:1123-1129 (1996).
10. B. Avalosse, F. Dupont, and A. Burny. Gene therapy for cancer. Curr. Opin. Oncol. 7:94-100 (1995).
11. T. Inazawa, T. Tanabe, H. Yamada, T. Nakaoka, Y. Hashimoto, T. Yamasaki, H. Kotaki, K. Tani, S. Asano, and N. Yamashita. Glucocorticoid-regulated expression of exogenous human growth hormone gene in rats. Mol. Ther. 4:267-272 (2001).
12. W. Lee, P. Mitchell, and R. Tjian. Purified transcriotional factor AP-1 interacts with TPA inducible elements. Cell 49:741-752 (1987).
13. X. Li and A. Y. Sun. Paraquat induced activation of transcriptional factor AP-1 and apotosis in PC12 cells. J. Neural. Transm. 106:1-21 (1996).
14. T. Curran. FOS and JUN: oncogenic transcriptional factors. Tohoku J. Exp. Med. 168:169-174 (1992).
15. D. Forrest and T. Curran. Crossed signals: oncogenis transcriptional factors. Curr. Opin. Genet. Dev. 2:19-27 (1992).
16. T. Usui, Y. Saitoh, and F. Komada. Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol. Pharm. Bull. 26:510-517 (2003).
17. F. Komada, K. Nishiguchi, Y. Tanigawara, T. Akamatsu, X. Y. Wu, S. Iwakawa, and K. Okumura. Effect of transfection with superoxide dismutase expression plasmid on superoxide anion induced cytotoxicity in cultured rat lung cells. Biol. Pharm. Bull. 19:274-279 (1996).
18. K. Nishiguchi, K. Ishida, M. Nakajima, T. Maeda, F. Komada, S. Iwakawa, Y. Tanigawara, and K. Okumura. Pharmaceutical studies for gene therapy: expression of human Cu, Zn-superoxide dismutase gene transfected by lipofection in rat skin fibroblasts. Biol. Pharm. Bull. 19:1073-1077 (1996).
19. R. Chiu, W. J. Boyle, J. Meek, T. Smeal, T. Hunter, and M. Karin. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54:541-552 (1988).
20. T. Hai and T. Curran. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. U. S. A. 88:3720-3724 (1991).
21. M. Karin. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483-16486 (1995).
22. P. Angel and M. Karin. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochem. Biophys. Acta. 1072:129-157 (1991).
23. P. Angel, M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. Phorbol esteri-nducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739 (1987).
24. W. Lee, P. Mitchell, and R. Tajian. Purified transcription factor AP-1 interacts with TPA inducible elements. Cell 49:741-752 (1987).
25. M. C. Hollander and A. J. J. Fornace. Induction of fos RNA by DNA-damaging agents. Cancer Res. 49:1687-1692 (1989).
26. M. Buscher, H. J. Rahmsdorf, M. Liftin, M. Karin, and P. Herrlich. Activation of the c-fos gene by UV and phorbor ester: different signal transduction pathway converge to the same enhancer element. Oncogene 3:301-311 (1988).
27. M. Djavaheri-Mergny, J. L. Mergny, F. Bertrand, R. Santus, C. Maziere, L. Dubertret, and J. C. Maziere. Ultraviolet-A induces activation of AP-1 in cultured human keratinocytes. FEBS Lett. 384:92-96 (1996).
28. N. H. Heintz, Y. M. Janssen, and B. T. Mossman. Persistent induction of c-fos and c-jun expression by asbestos. Proc. Natl. Acad. Sci. U. S. A. 90:3299-3303 (1993).
29. A. Puga, D. W. Nebert, and F. Carrier. Dioxin induces expression of c-fos and c-jun proto-oncogenes and large increase in transcriptional factor AP-1. DNA. Cell Biol. 11:269-281 (1992).
30. S. Srinivasan, M. E. Hatley, D. T. Bolick, L. A. Palmer, D. Edelstein, M. Brownlee, and C. C. Hedrick. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 47:1727-1734 (2004).
31. J. Springer, D. Pleimes, F. R. Scholz, and A. Fischer. Substance P mediates AP-1 induction in A549 cells via reactive oxygen species. Regul. Pept. 124:99-103 (2005).
32. M. H. Kim, H. S. Cho, M. Jung, M. H. Hong, S. K. Lee, B. A. Shin, B. W. Ahn, and Y. D. Jung. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. Int. J. Oncol. 26:1669-1674 (2005).
33. U. Vollgraf, M. Wegner, and C. Richter-Landsberg. Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J. Neurochem. 73:2501-2509 (1999).
34. L. Z. Zhou, A. P. Johnson, and T. A. Rando. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 31:1405-1416 (2001).
35. T. Fukushima, K. Yamada, N. Honjo, A. Isobe, K. Shiwaku, and Y. Yamane. Mechanism of cytotoxicity of paraquat. III. The effects of acute paraquat exposure on the electron transport system in rat mitochondria. Exp. Toxicol. Pathol. 46:431-441 (1994).
36. S. Nakagawa and T. Mayumi. Development of novel technology of DDS for gene therapy. Drug Metab. Pharmacokin. 18:223-229 (2003).
37. Z. Zhu, T. Zheng, C. G. Lee, R. J. Homera, and J. A. Elias. Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Semin. Cell Dev. Biol. 13:121-128 (2002).
38. R. T. Dorr. Cytoprotective agents for anthracyclines. Semin. Oncol. 23:23-34 (1996).